New COVID Pill Shows the Need for Widescale Testing

November 8, 2021

(Axios) – Pfizer’s new COVID-19 antiviral is highly effective when given early in the course of an infection — underscoring the importance of cheap, easily accessible COVID-19 tests, including at-home rapid versions. Driving the news: Pfizer’s oral antiviral drug reduced the risk of hospitalization or death from COVID-19 by 89%, according to interim results from a mid-to-late-stage study announced by the company on Friday, my colleague Rebecca Falconer writes.  (Read Full Article)